There is an ongoing need for relevant animal models in which to test therapeutic interventions for infants with neurological sequelae of prematurity. The ferret is an attractive model species as it has a gyrified brain with a white-to-gray matter ratio similar to that in the human brain. A model of encephalopathy of prematurity was developed in postnatal day 10 (P10) ferret kits, considered to be developmentally equivalent to infants of 24–26 weeks’ gestation. Cross-fostered P10 ferret kits received 5 mg/kg of lipopolysaccharide (LPS) before undergoing consecutive hypoxia-hyperoxia-hypoxia (60 min at 9%, 120 min at 60%, and 30 min at 9%). Control animals received saline vehicle followed by normoxia. The development of basic reflexes (negative geotaxis, cliff aversion, and righting) as well as gait coordination on an automated catwalk were assessed between P28 and P70, followed by ex vivo magnetic resonance imaging (MRI) and immunohistochemical analysis. Compared to controls, injured animals had slower overall reflex development between P28 and P40, as well as smaller hind-paw areas consistent with “toe walking” at P42. Injured animals also displayed significantly greater lateral movement during CatWalk assessment as a result of reduced gait coordination. Ex vivo MRI showed widespread white-matter hyperintensity on T2-weighted imaging as well as altered connectivity patterns. This coincided with white-matter dysmaturation characterized by increased intensity of myelin basic protein staining, white-matter thinning, and loss of oligodendrocyte transcription factor 2 (OLIG2)-positive cells. These results suggest both pathological and motor deficits consistent with premature white-matter injury. This newborn ferret model can therefore provide an additional platform to assess potential therapies before translation to human clinical trials.

1.
Martin
JA
,
Hamilton
BE
,
Osterman
MJ
, et al.
Births: Final Data for 2016. National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics
.
National Vital Statistics System.
2018
;
67
(
1
):
1
55
.
2.
Younge
N
,
Goldstein
RF
,
Bann
CM
,
Hintz
SR
,
Patel
RM
,
Smith
PB
, et al.;
Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network
.
Survival and Neurodevelopmental Outcomes among Periviable Infants
.
N Engl J Med
.
2017
Feb
;
376
(
7
):
617
28
.
[PubMed]
0028-4793
3.
Johnson
S
,
Marlow
N
.
Early and long-term outcome of infants born extremely preterm
.
Arch Dis Child
.
2017
Jan
;
102
(
1
):
97
102
.
[PubMed]
0003-9888
4.
Galinsky
R
,
Polglase
GR
,
Hooper
SB
,
Black
MJ
,
Moss
TJ
.
The consequences of chorioamnionitis: preterm birth and effects on development
.
J Pregnancy
.
2013
;
2013
:
412831
.
[PubMed]
2090-2727
5.
Reich
B
,
Hoeber
D
,
Bendix
I
,
Felderhoff-Mueser
U
.
Hyperoxia and the Immature Brain
.
Dev Neurosci
.
2016
;
38
(
5
):
311
30
.
[PubMed]
0378-5866
6.
Bennet
L
,
Dhillon
S
,
Lear
CA
,
van den Heuij
L
,
King
V
,
Dean
JM
, et al.
Chronic inflammation and impaired development of the preterm brain
.
J Reprod Immunol
.
2018
Feb
;
125
:
45
55
.
[PubMed]
0165-0378
7.
Galinsky
R
,
Lear
CA
,
Dean
JM
,
Wassink
G
,
Dhillon
SK
,
Fraser
M
, et al.
Complex interactions between hypoxia-ischemia and inflammation in preterm brain injury
.
Dev Med Child Neurol
.
2018
Feb
;
60
(
2
):
126
33
.
[PubMed]
0012-1622
8.
Empie
K
,
Rangarajan
V
,
Juul
SE
.
Is the ferret a suitable species for studying perinatal brain injury?
Int J Dev Neurosci
.
2015
Oct
;
45
:
2
10
.
[PubMed]
0736-5748
9.
Schwerin
SC
,
Chatterjee
M
,
Imam-Fulani
AO
,
Radomski
KL
,
Hutchinson
EB
,
Pierpaoli
CM
, et al.
Progression of histopathological and behavioral abnormalities following mild traumatic brain injury in the male ferret
.
J Neurosci Res
.
2018
Apr
;
96
(
4
):
556
72
.
[PubMed]
0360-4012
10.
Rafaels
KA
,
Bass
CR
,
Panzer
MB
,
Salzar
RS
,
Woods
WA
,
Feldman
SH
, et al.
Brain injury risk from primary blast
.
J Trauma Acute Care Surg
.
2012
Oct
;
73
(
4
):
895
901
.
[PubMed]
2163-0755
11.
Snyder
JM
,
Wood
TR
,
Corry
K
,
Moralejo
DH
,
Parikh
P
,
Juul
SE
.
Ontogeny of white matter, toll-like receptor expression, and motor skills in the neonatal ferret
.
Int J Dev Neurosci
.
2018
Nov
;
70
:
25
33
.
[PubMed]
0736-5748
12.
Barnette
AR
,
Neil
JJ
,
Kroenke
CD
, et al.
Characterization of Brain Development in the Ferret via Magnetic Resonance Imaging
.
Pediatr Res
.
2009
;
66
(
1
):
80
4
.
[PubMed]
0031-3998
13.
Noctor
SC
,
Scholnicoff
NJ
,
Juliano
SL
.
Histogenesis of ferret somatosensory cortex
.
J Comp Neurol
.
1997
Oct
;
387
(
2
):
179
93
.
[PubMed]
0021-9967
14.
Eklind
S
,
Mallard
C
,
Leverin
AL
,
Gilland
E
,
Blomgren
K
,
Mattsby-Baltzer
I
, et al.
Bacterial endotoxin sensitizes the immature brain to hypoxic—ischaemic injury
.
Eur J Neurosci
.
2001
Mar
;
13
(
6
):
1101
6
.
[PubMed]
0953-816X
15.
Falck
M
,
Osredkar
D
,
Wood
TR
,
Maes
E
,
Flatebø
T
,
Sabir
H
, et al.
Neonatal Systemic Inflammation Induces Inflammatory Reactions and Brain Apoptosis in a Pathogen-Specific Manner
.
Neonatology
.
2018
;
113
(
3
):
212
20
.
[PubMed]
1661-7800
16.
Osredkar
D
,
Sabir
H
,
Falck
M
,
Wood
T
,
Maes
E
,
Flatebø
T
, et al.
Hypothermia Does Not Reverse Cellular Responses Caused by Lipopolysaccharide in Neonatal Hypoxic-Ischaemic Brain Injury
.
Dev Neurosci
.
2015
;
37
(
4-5
):
390
7
.
[PubMed]
0378-5866
17.
Nakata
M
,
Itou
T
,
Sakai
T
.
Quantitative analysis of inflammatory cytokines expression in peripheral blood mononuclear cells of the ferret (Mustela putorius furo) using real-time PCR
.
Vet Immunol Immunopathol
.
2009
Jul
;
130
(
1-2
):
88
91
.
[PubMed]
0165-2427
18.
Rubinov
M
,
Sporns
O
.
Complex network measures of brain connectivity: uses and interpretations
.
Neuroimage
.
2010
Sep
;
52
(
3
):
1059
69
.
[PubMed]
1053-8119
19.
Fair
DA
,
Cohen
AL
,
Dosenbach
NU
,
Church
JA
,
Miezin
FM
,
Barch
DM
, et al.
The maturing architecture of the brain’s default network
.
Proc Natl Acad Sci USA
.
2008
Mar
;
105
(
10
):
4028
32
.
[PubMed]
0027-8424
20.
Fair
DA
,
Cohen
AL
,
Power
JD
, et al.
Functional brain networks develop from a "local to distributed" organization. PLoS computational biology.
2009
;5(5):e1000381-e.
21.
Fair
DA
,
Dosenbach
NU
,
Church
JA
,
Cohen
AL
,
Brahmbhatt
S
,
Miezin
FM
, et al.
Development of distinct control networks through segregation and integration
.
Proc Natl Acad Sci USA
.
2007
Aug
;
104
(
33
):
13507
12
.
[PubMed]
0027-8424
22.
Gong
G
,
Rosa-Neto
P
,
Carbonell
F
,
Chen
ZJ
,
He
Y
,
Evans
AC
.
Age- and gender-related differences in the cortical anatomical network
.
J Neurosci
.
2009
Dec
;
29
(
50
):
15684
93
.
[PubMed]
0270-6474
23.
Meunier
D
,
Achard
S
,
Morcom
A
,
Bullmore
E
.
Age-related changes in modular organization of human brain functional networks
.
Neuroimage
.
2009
Feb
;
44
(
3
):
715
23
.
[PubMed]
1053-8119
24.
Buckner
RL
,
Sepulcre
J
,
Talukdar
T
,
Krienen
FM
,
Liu
H
,
Hedden
T
, et al.
Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer’s disease
.
J Neurosci
.
2009
Feb
;
29
(
6
):
1860
73
.
[PubMed]
0270-6474
25.
Liu
Y
,
Liang
M
,
Zhou
Y
,
He
Y
,
Hao
Y
,
Song
M
, et al.
Disrupted small-world networks in schizophrenia
.
Brain
.
2008
Apr
;
131
(
Pt 4
):
945
61
.
[PubMed]
0006-8950
26.
Wang
L
,
Zhu
C
,
He
Y
,
Zang
Y
,
Cao
Q
,
Zhang
H
, et al.
Altered small-world brain functional networks in children with attention-deficit/hyperactivity disorder
.
Hum Brain Mapp
.
2009
Feb
;
30
(
2
):
638
49
.
[PubMed]
1065-9471
27.
Dobbing
J
,
Sands
J
.
Comparative aspects of the brain growth spurt
.
Early Hum Dev
.
1979
Mar
;
3
(
1
):
79
83
.
[PubMed]
0378-3782
28.
McPherson
RJ
,
Juul
SE
.
Erythropoietin for infants with hypoxic-ischemic encephalopathy
.
Curr Opin Pediatr
.
2010
Apr
;
22
(
2
):
139
45
.
[PubMed]
1040-8703
29.
Traudt
CM
,
McPherson
RJ
,
Bauer
LA
,
Richards
TL
,
Burbacher
TM
,
McAdams
RM
, et al.
Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia
.
Dev Neurosci
.
2013
;
35
(
6
):
491
503
.
[PubMed]
0378-5866
30.
Chakkarapani
E
,
Dingley
J
,
Aquilina
K
,
Osredkar
D
,
Liu
X
,
Thoresen
M
.
Effects of xenon and hypothermia on cerebrovascular pressure reactivity in newborn global hypoxic-ischemic pig model
.
J Cereb Blood Flow Metab
.
2013
Nov
;
33
(
11
):
1752
60
.
[PubMed]
0271-678X
31.
Dingley
J
,
Tooley
J
,
Liu
X
,
Scull-Brown
E
,
Elstad
M
,
Chakkarapani
E
, et al.
Xenon ventilation during therapeutic hypothermia in neonatal encephalopathy: a feasibility study
.
Pediatrics
.
2014
May
;
133
(
5
):
809
18
.
[PubMed]
0031-4005
32.
Thoresen
M
,
Hobbs
CE
,
Wood
T
,
Chakkarapani
E
,
Dingley
J
.
Cooling combined with immediate or delayed xenon inhalation provides equivalent long-term neuroprotection after neonatal hypoxia-ischemia
.
J Cereb Blood Flow Metab
.
2009
Apr
;
29
(
4
):
707
14
.
[PubMed]
0271-678X
33.
Zhou
J
,
Butler
EE
,
Rose
J
.
Neurologic Correlates of Gait Abnormalities in Cerebral Palsy: implications for Treatment
.
Front Hum Neurosci
.
2017
Mar
;
11
:
103
.
[PubMed]
1662-5161
34.
Jantzie
LL
,
Robinson
S
.
Preclinical Models of Encephalopathy of Prematurity
.
Dev Neurosci
.
2015
;
37
(
4-5
):
277
88
.
[PubMed]
0378-5866
35.
Durán-Carabali
LE
,
Arcego
DM
,
Odorcyk
FK
,
Reichert
L
,
Cordeiro
JL
,
Sanches
EF
, et al.
Prenatal and Early Postnatal Environmental Enrichment Reduce Acute Cell Death and Prevent Neurodevelopment and Memory Impairments in Rats Submitted to Neonatal Hypoxia Ischemia
.
Mol Neurobiol
.
2018
May
;
55
(
5
):
3627
41
.
[PubMed]
1559-1182
36.
Johnston
MV
,
Fatemi
A
,
Wilson
MA
,
Northington
F
.
Treatment advances in neonatal neuroprotection and neurointensive care
.
Lancet Neurol
.
2011
Apr
;
10
(
4
):
372
82
.
[PubMed]
1474-4422
37.
Sheldon
RA
,
Aminoff
A
,
Lee
CL
,
Christen
S
,
Ferriero
DM
.
Hypoxic preconditioning reverses protection after neonatal hypoxia-ischemia in glutathione peroxidase transgenic murine brain
.
Pediatr Res
.
2007
Jun
;
61
(
6
):
666
70
.
[PubMed]
0031-3998
38.
Garipis
N
,
Hoffmann
KP
.
Visual field defects in albino ferrets (Mustela putorius furo)
.
Vision Res
.
2003
Mar
;
43
(
7
):
793
800
.
[PubMed]
0042-6989
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.